Skip to main content

Table 3 Clinical characteristics and echocardiographic measurements of three sub-groups

From: Investigation on left ventricular multi-directional deformation in patients of hypertension with different LVEF

 

group A

group B

group C

n = 71

n = 13

n = 34

Age(y)

57.99 ± 11.94

56.31 ± 14.07

57.62 ± 14.42

Gender(M/F)

53/18

11/2

28/6

HR(beats/min)

69.54 ± 11.97

66.92 ± 9.67

80.50 ± 15.81

LVIDd(cm)

5.17 ± 0.56

5.61 ± 0.47

6.10 ± 0.88

RWT

0.44 ± 0.10

0.41 ± 0.11

0.38 ± 0.12

LVEDVI(ml/ m2)

74.61 ± 15.56

91.14 ± 19.56

114.97 ± 41.34

LVMI(g/ m2)

132.09 ± 44.70

151.45 ± 42.37

181.44 ± 51.20

LAD(cm)

3.99 ± 0.56

4.11 ± 0.66

4.45 ± 0.64

LAVI(ml/m2)

31.33 ± 9.19

31.91 ± 9.76

42.69 ± 17.71

LVEF(%)

62.65 ± 4.14

49.45 ± 2.51

34.79 ± 7.24

s(m/s)

0.07 ± 0.03

0.06 ± 0.02

0.05 ± 0.02

E/e

11.13 ± 4.17

11.19 ± 3.79

18.76 ± 11.78

e(m/s)

0.07 ± 0.06

0.06 ± 0.03

0.05 ± 0.02

  1. Data are expressed as mean ± standard deviation (SD) or as number (ratio); HR heart rate, LVIDd Left ventricular internal dimension in diastole, RWT Relative wall thickness, LVEDVI Left ventricular end-diastolic volume index, LVMI Left ventricular mass index, LAD Left atrial diameter, LAVI LA volume index, LVEF Left ventricular ejection fraction; the data of normal controls (NC) see Table one; group A, normal LVEF and LV end diastolic volume index, group B, “borderline” LVEF and enlarged LV end diastolic volume index, group C, reduced LVEF (LVEF < 45%). p < 0.05 vs NC; p < 0.05 vs group A; p < 0.05 group B